Eargo SE vs Otofonix Groove

The Eargo SE is a premium-priced OTC hearing aid at $1,699, featuring an invisible-in-ear design and earning a B grade with a SoundScore of 3.1/5 in our lab testing. This places it in the top 85% of the OTC hearing aid category, ranking #56 of 65 devices tested. In our testing, the Eargo SE demonstrated solid performance in speech clarity for quiet environments, scoring 3.2/5—0.43 points above the category average. Feedback handling was excellent at 4.6/5, meaning users should experience stable performance without whistling issues. However, the device showed limitations in challenging listening situations, with speech in noise scoring 1.3/5, which falls 0.23 points below the category average. A notable weakness is the complete absence of music streaming capability, scoring 0.0/5 compared to the category average of 1.92/5. Own-voice comfort scored 2.4/5, slightly below the category average. These mixed results suggest the Eargo SE prioritizes its discreet form factor over comprehensive audio features. The Eargo SE may appeal to users who prioritize an invisible design and primarily need help hearing conversations in quieter settings. However, given its premium price point and the availability of alternatives like the Jabra Enhance Select 50R that deliver stronger overall scores at lower prices, value-conscious consumers may want to explore other options before committing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.